A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer
Phase 2 Terminated
50 enrolled 18 charts
AcceleRET-Lung
Phase 3 Terminated
223 enrolled 18 charts
Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer
Phase 1/2 Terminated
34 enrolled 15 charts
OTT15-04
Phase 4 Terminated
2 enrolled 4 charts
A Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants With Homologous Recombination-Deficient Stage III/IV Ovarian Cancer (COHORT-C)
Phase 2 Terminated
36 enrolled 11 charts
ELEVATE TNBC
Phase 2 Terminated
92 enrolled 27 charts
Pembro+Chemo in Brain Mets
Phase 2 Terminated
3 enrolled 7 charts
A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors
Phase 1 Terminated
62 enrolled 25 charts
Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Phase 1/2 Terminated
137 enrolled 31 charts
ARTISTRY-7
Phase 3 Terminated
456 enrolled 19 charts
TATEN
Phase 2 Terminated
20 enrolled 19 charts
nextHERIZON
Phase 2 Terminated
7 enrolled 8 charts
A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
1 enrolled 4 charts
Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
Phase 3 Terminated
96 enrolled 16 charts
FORTITUDE-201
Phase 1 Terminated
74 enrolled 22 charts
A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer
Phase 1/2 Terminated
36 enrolled 26 charts
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase 2 Terminated
23 enrolled 10 charts
VELIA
Phase 3 Terminated
1,140 enrolled 29 charts
A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLC
Phase 3 Terminated
8 enrolled 6 charts
QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer
Phase 1/2 Terminated
15 enrolled 11 charts
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
Phase 2 Terminated
17 enrolled 12 charts
Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer
Phase 3 Terminated
8 enrolled 7 charts
Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 1/2 Terminated
12 enrolled 8 charts
Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 2 Terminated
9 enrolled 9 charts
SUMMIT
Phase 2 Terminated
582 enrolled 27 charts
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
153 enrolled 13 charts
Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer
Phase 2 Terminated
15 enrolled 9 charts
First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
Phase 2 Terminated
36 enrolled 14 charts
CanStem43L
Phase 3 Terminated
4 enrolled 6 charts
Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer
Phase 1/2 Terminated
9 enrolled 12 charts
Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).
Phase 2 Terminated
26 enrolled 11 charts
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer
Phase 2 Terminated
31 enrolled 8 charts
Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer
Phase 2 Terminated
4 enrolled 6 charts
Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer
Phase 2 Terminated
7 enrolled 10 charts
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer
Phase NA Terminated
14 enrolled 5 charts
Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer
Phase 1/2 Terminated
7 enrolled 11 charts
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Phase 3 Terminated
1,333 enrolled 22 charts
MK-4440-001
Phase 1 Terminated
78 enrolled 28 charts
ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib
Phase 3 Terminated
63 enrolled 22 charts
Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery
Phase 2 Terminated
8 enrolled 7 charts
A Study of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has Spread
Phase 2 Terminated
169 enrolled 31 charts
MK-3475-063
Phase 3 Terminated
94 enrolled 17 charts
PROPEL
Phase 1/2 Terminated
162 enrolled 21 charts
Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells
Phase 2 Terminated
7 enrolled 8 charts
Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours
Phase 1 Terminated
22 enrolled 27 charts
Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients w/ Body Surface Area (BSA) > 2.0
Phase 2 Terminated
3 enrolled 8 charts
A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGelâ„¢ in Subjects With Recurrent Glioma
Phase 1/2 Terminated
4 enrolled 5 charts
Trial of NanoPac Focal Therapy for Prostate Cancer
Phase 2 Terminated
1 enrolled 5 charts
Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma
Phase 1/2 Terminated
12 enrolled 8 charts
EVA
Phase 2 Terminated
26 enrolled 16 charts